Rick E Winningham
Director; Director, CHIEF EXECUTIVE OFFICER · 3 filings · Latest: May 22, 2026
Jazz Pharmaceuticals plc
Theravance Biopharma, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
JAZZ | Rick E Winningham | Director | May 22, 2026 | Sale | $241.57 | 2,741 | $662.1K | 9,567 | |
JAZZ | Rick E Winningham | Director | May 22, 2026 | Option Exercise | $138.08 | 3,415 | $471.5K | 12,308 | |
TBPH | Rick E Winningham | Director, CHIEF EXECUTIVE OFFICER | May 20, 2026 | Tax Withholding | $16.55 | 20,038 | $331.6K | 1,631,056 | |
TBPH | Rick E Winningham | Director, CHIEF EXECUTIVE OFFICER | Apr 1, 2026 | Grant/Award | $0.00 | 75,000 | — | 1,651,094 |